CONMED Corporation (CNMD)

Financial leverage ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total assets	US$ in thousands	2,306,250	2,315,740	2,285,620	2,309,260	2,300,020	2,325,680	2,322,720	2,320,120	2,297,590	2,292,040	2,072,260	1,785,720	1,766,020	1,754,090	1,761,970	1,746,610	1,751,670	1,743,130	1,723,910	1,750,970
Total stockholders’ equity	US$ in thousands	962,681	932,896	881,832	854,664	834,222	796,205	780,194	752,453	745,545	716,337	672,968	789,546	785,435	755,683	744,499	725,570	709,038	683,141	674,898	701,635
Financial leverage ratio		2.40	2.48	2.59	2.70	2.76	2.92	2.98	3.08	3.08	3.20	3.08	2.26	2.25	2.32	2.37	2.41	2.47	2.55	2.55	2.50

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $2,306,250K ÷ $962,681K
= 2.40

The financial leverage ratio of CONMED Corporation has shown a fluctuating trend over the past few years. The ratio increased from 2.50 as of March 31, 2020, to a peak of 3.20 as of September 30, 2022, before decreasing to 2.40 as of December 31, 2024. This indicates that the company's reliance on debt to finance its operations has varied significantly.

A higher financial leverage ratio suggests that the company is using more debt in its capital structure, which can amplify returns but also increase financial risk. Conversely, a lower ratio indicates a more conservative approach to debt financing.

It is essential for stakeholders to closely monitor the financial leverage ratio, as changes in this metric can impact the company's overall financial health and risk profile. The recent decrease in the ratio from 3.20 in September 2022 to 2.40 in December 2024 may indicate a shift towards a more balanced capital structure or a reduction in leverage, which could potentially improve the company's financial stability.